Inhibitors of antigen presentation by MHC Class II molecules and methods of use thereof

Details for Australian Patent Application No. 2008331789 (hide)

Owner Provid Pharmaceuticals, Inc.

Inventors Self, Christopher R.; Olson, Gary L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008331789

PCT Pub. Number WO2009/073168

Priority 61/005,290 03.12.07 US

Filing date 2 December 2008

Wipo publication date 11 June 2009

International Classifications

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/073168 Priority application(s): WO2009/073168

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008331795-Encryption for soft earning unit

2008331769-Controlled atmosphere package for bananas